ChiCTR2200057335 版本V1.2 版本创建时间2022/11/09 10:46:18 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200057335 

最近更新日期:

Date of Last Refreshed on:

2022-11-09 10:44:38 

注册时间:

Date of Registration:

2022-03-08 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

开四关配合导引治疗延迟性肌肉酸痛的临床疗效观察

Public title:

Acupuncture “Si Guan” with conduction exercise in delayed-onset muscle soreness

注册题目简写:

English Acronym:

研究课题的正式科学名称:

开四关配合导引治疗延迟性肌肉酸痛的临床疗效观察和治疗策略优化的研究

Scientific title:

Acupuncture “Si Guan” with conduction exercise in delayed-onset muscle soreness and treatment strategy optimization

研究课题代号(代码):

Study subject ID:

QL20210177

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

徐璇 

研究负责人:

刘密 

Applicant:

Xuan Xu 

Study leader:

Mi Liu 

申请注册联系人电话:

Applicant telephone:

+86 8273178615

研究负责人电话:

Study leader's
telephone:

+86 15116387811

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

xu_xuan666@163.com

研究负责人电子邮件:

Study leader's E-mail:

newmean9722@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖南省长沙市岳麓区学士路300号

研究负责人通讯地址:

湖南省长沙市岳麓区学士路300号湖南中医药大学

Applicant address:

300 Xuesheng Road, Yuelu District, Changsha, Hunan

Study leader's address:

300 Xuesheng Road, Yuelu District, Changsha, Hunan

申请注册联系人邮政编码:

Applicant postcode:

410208

研究负责人邮政编码:

Study leader's postcode:

410208

申请人所在单位:

湖南中医药大学

Applicant's institution:

Hunan University of Chinese Medicine

研究负责人所在单位:

湖南中医药大学

Affiliation of the Leader:

Hunan University of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2022-KY-004

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

湖南中医药大学第二附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of the Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2022-01-25 00:00:00

伦理委员会联系人:

朱明芳

Contact Name of the ethic committee:

Mingfang Zhu

伦理委员会联系地址:

湖南省长沙市开福区蔡锷北路233号

Contact Address of the ethic committee:

233 Caie Road North, Kaifu District, Changsha, Hunan

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 0731-84917719

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

湖南中医药大学

Primary sponsor:

Hunan University of Chinese Medicine

研究实施负责(组长)单位地址:

湖南省长沙市岳麓区学士路300号

Primary sponsor's address:

300 Xuesheng Road, Yuelu District, Changsha, Hunan

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖南

市(区县):

长沙

Country:

China

Province:

Hu'nan

City:

Changsha

单位(医院):

湖南中医药大学

具体地址:

湖南省长沙市岳麓区学士路300号

Institution
hospital:

Hunan University of Chinese Medicine

Address:

300 Xuesheng Road, Yuelu District, Changsha, Hunan

经费或物资来源:

湖南省研究生科研创新项目(QL20210177)

Source(s) of funding:

Hunan Graduate Scientific Research Innovation Project

研究疾病:

延迟性肌肉酸痛  

Target disease:

Delayed-Onset Muscle Soreness

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

观察针刺四关配合运动和呼吸导引治疗延迟性肌肉酸痛的临床疗效并研究治疗策略的优化  

Objectives of Study:

Observe the clinical effect of acupuncture siguan combined with movement and breathing conduction exercise in the treatment of delayed-onset muscle soreness and study the optimization of treatment strategy

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 年龄18~30岁;
2. 下肢近2周无规律锻炼或剧烈运动 ;
3. 入组时下肢无不适;
4. 能够接受针灸治疗。

Inclusion criteria

1. 18-30 years old;
2. The lower limbs did not exercise regularly or vigorously for nearly 2 weeks;
3. There was no discomfort in lower limbs at the time of enrollment;
4. Able to receive acupuncture treatment.

排除标准:

1. 心血管及呼吸系统疾病;
2. 下肢运动系统严重疾病;
3. 下肢血管疾病;
4. 其他可能在剧烈运动后出现威胁生命安全的不适症状。

Exclusion criteria:

1. Cardiovascular and respiratory diseases;
2. Serious disease of the lower limb motor system;
3. Lower limb vascular diseases;
4. Other life-threatening uncomfortable symptoms may occur after strenuous exercise.

研究实施时间:

Study execute time:

From 2021-12-01 00:00:00 To 2022-08-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-03-01 00:00:00 To 2022-05-31 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

12

Group:

Observation group

Sample size:

干预措施:

观察

干预措施代码:

Intervention:

Observe

Intervention code:

组别:

对照组

样本量:

12

Group:

Control group

Sample size:

干预措施:

冷疗

干预措施代码:

Intervention:

Cold therapy

Intervention code:

组别:

治疗组A

样本量:

12

Group:

Treatment group A

Sample size:

干预措施:

针刺四关配合肢体和呼吸导引

干预措施代码:

Intervention:

Acupuncture siguan with movement and breathing conduction exercise

Intervention code:

组别:

治疗组B

样本量:

12

Group:

Treatment group B

Sample size:

干预措施:

针刺四关配合呼吸导引

干预措施代码:

Intervention:

Acupuncture siguan with breathing conduction exercise

Intervention code:

组别:

治疗组C

样本量:

12

Group:

Treatment group C

Sample size:

干预措施:

针刺四关配合肢体导引

干预措施代码:

Intervention:

Acupuncture siguan with movement conduction exercise

Intervention code:

组别:

假针刺组

样本量:

12

Group:

Sham acupuncture group

Sample size:

干预措施:

假针刺配合肢体和呼吸导引

干预措施代码:

Intervention:

Sham acupuncture with movement and breathing conduction exercise

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖南 

市(区县):

长沙 

Country:

China

Province:

Hu'nan

City:

Changsha

单位(医院):

湖南中医药大学 

单位级别:

大学 

Institution
hospital:

Hunan University of Chinese Medicine

Level of the institution:

University

测量指标:

Outcomes:

指标中文名:

VAS疼痛量表

指标类型:

主要指标

Outcome:

Visual analogue scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

6级疼痛表

指标类型:

次要指标

Outcome:

Level 6 pain scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

局部压痛阈值

指标类型:

次要指标

Outcome:

Local tenderness threshold

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

百度网盘

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

BAIDU CLOUD

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2022-03-08 18:01:56